Safety Study of BJ-001, an IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors

Clinical trial NCT04294576 · UNKNOWN

Trial details

NCT number: NCT04294576
Sponsor: BJ Bioscience, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced/Metastatic Solid Tumors

Start date: 2019-12-04
Primary completion: 2024-04-29
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.